Quantcast
Nearly 1 In 5 Adults Have Persistent Pain Study

Nearly 1 In 5 Adults Have Persistent Pain: Study

Provided by Eric Sorensen, Washington State University Americans are in a world of hurt. Nearly one in five US adults are in pain most every day for spells of three months or longer, according to an analysis by Jae Kennedy, professor of health...

Latest Methadone Stories

2014-10-29 23:07:28

Affordable cessation drugs, combined with 12-step programs, help conquer addictions New York, NY (PRWEB) October 29, 2014 Opioid addiction is characterized as an inability to stop using opiates like oxycodone, heroin, morphine, or hydrocodone. This type of addiction is devastating and deadly. The CDC reports that each day, over 100 people in the U.S. die from a prescription drug overdose—either when taking more than the recommended dosage, or when people take pills that were not...

2014-10-29 08:33:42

WAYNE, Pa., Oct. 29, 2014 /PRNewswire/ -- Egalet Corporation (Nasdaq: EGLT) ("Egalet") today announced that its third quarter financial results will be released on Wednesday, November 12, 2014. Following the announcement, Egalet's management will host a live conference call and webcast at 8:30 am Eastern Time to review the Company's financial and operating results and provide a general business update. The live webcast and a replay may be accessed by visiting Egalet's website....

2014-10-28 08:36:58

WAISMANN METHOD® Medical Director Recognizes Patient Trend and Suggests Strategies to Address Potential Dependency Issues ORANGE, Calif., Oct. 28, 2014 /PRNewswire/ -- New data suggests the U.S. Drug Enforcement Agency's crackdown on Hydrocodone prescriptions has positively affected painkiller-related deaths, with a 5 percent decrease. However, according to a study by the Centers for Disease Control and Prevention (CDC), heroin deaths have doubled in the past two years, leading...

2014-10-28 08:34:53

Complementary to BUNAVAIL(TM); Potential to Leverage Current Addiction Sales Force RALEIGH, N.C., Oct. 28, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (BDSI) (NASDAQ: BDSI) has entered into an exclusive agreement with Evonik Corporation to develop and commercialize a proprietary, injectable microparticle formulation of buprenorphine potentially capable of providing 30 days of continuous therapy following a single subcutaneous injection....

2014-10-27 16:28:51

- Henrico County Sheriff's Office to Receive First Donation - RICHMOND, Va., Oct. 27, 2014 /PRNewswire/ -- Kaleo, a privately-held pharmaceutical company headquartered in Richmond, Virginia, today announced a new donation program that will allow qualifying local law enforcement agencies to receive EVZIO(TM) naloxone auto-injectors without charge as part of the kaleo Cares program. EVZIO, approved by the U.S. Food and Drug Administration (FDA) on April 3, 2014, is an opioid antagonist...

2014-10-23 23:13:17

In a new blog post, Best Drug Rehabilitation, which offers treatment programs and believes that having family close by during a stay in rehab can make a big difference in whether or not the process is successful, is listing the top 6 things never to say to a recovering addict. (PRWEB) October 23, 2014 In a new blog post, Best Drug Rehabilitation, which offers treatment programs and believes that having family close by during a stay in rehab can make a big difference in whether or not the...

2014-10-22 08:32:56

Pain Insights, Inc. releases a comprehensive market research study on the impact of hydrocodone rescheduling, Zohydro(TM) ER, and abuse-deterrent formulations on prescribers and the pain market. FAIRFIELD, N.J., Oct. 22, 2014 /PRNewswire/ -- Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study by Pain Insights, Inc., a firm providing market research and consultation exclusively in the...

2014-10-21 08:33:43

Company's new identity to reflect its enhanced focus in chronic diseases of addiction RICHMOND, Va., Oct. 21, 2014 /PRNewswire/ -- Reckitt Benckiser Pharmaceuticals Inc. (RBP) today announced its UK-based parent company, Reckitt Benckiser Group plc (RB), expects the proposed demerger of the RBP business to complete in 2014. Reckitt Benckiser originally announced plans to demerge the RBP business in late July 2014, and the operational and financial separations, appointment of the new...

2014-10-20 08:31:08

Contrave is now available by prescription, and Contrave patients also have access to the Scale Down program and Direct Save to help support their complete approach to weight management DEERFIELD, Ill. and OSAKA, Japan, Oct. 20, 2014 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda"), its wholly-owned subsidiary Takeda Pharmaceuticals U.S.A., Inc. and Orexigen(®) Therapeutics, Inc. (Nasdaq: OREX) jointly announced today that Contrave(®) (naltrexone HCI and bupropion HCI)...

2014-10-16 23:15:18

Residential Detoxification Program and Services See Recent Expansion Houston, TX (PRWEB) October 16, 2014 With a main office established a few miles south of Houston, Bay Area Recovery Center has helped thousands of people in the area recover from alcohol and drug abuse within the last 20 years. Recently, the rehabilitation center decided to expand the resources available for their residential detoxification programs. The addition of interactive multimedia, as well as expanded...


Word of the Day
maffling
  • To stammer.
  • Present participle of maffle, to stammer.
  • A simpleton.
The word 'maffle' may come from a Dutch word meaning 'to move the jaws' or a French word meaning 'having large cheeks'.